Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Verisante completes imager prototype

BioPhotonics
Nov 2013
Verisante Technology Inc. of Vancouver, British Columbia, Canada, has completed the second phase of a rapid multispectral imaging (MSI) system for skin cancer detection.

The prototype is currently undergoing laboratory testing at the BC Cancer Agency Research Centre before starting in vivo data collection for training the predictive algorithm for the device.

Verisante licensed the MSI technology from its inventors, Dr. Haishan Zeng and Dr. Yasser Fawzy of the BC Cancer Agency, for skin cancer and oral cancer detection as part of a broader acquisition strategy to enhance its intellectual property portfolio, which also includes white-light reflectance imaging, fluorescence imaging and rapid Raman spectroscopy.

The company will also explore the possibility of combining the MSI with its existing Aura device to determine whether the two technologies in tandem produce results with greater accuracy, since they are measuring different parameters. The Aura was awarded a 2013 Prism Award for photonics innovation by Photonics Media and SPIE, and an Edison Award for Excellence in Innovation in 2013.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!